tiprankstipranks
Advertisement
Advertisement

AU:LDX Stock Latest News

Lumos Diagnostics Issues New Shares on Employee Option Exercises and Confirms Regulatory Compliance
Company AnnouncementsLumos Diagnostics Issues New Shares on Employee Option Exercises and Confirms Regulatory Compliance
4d ago
LDX
Lumos Diagnostics Seeks Quotation for Additional ASX Shares
PremiumCompany Announcements
Lumos Diagnostics Seeks Quotation for Additional ASX Shares
4d ago
LDX
Lumos Director Doug Ward Increases On‑Market Shareholding
PremiumCompany Announcements
Lumos Director Doug Ward Increases On‑Market Shareholding
4d ago
LDX
Lumos Diagnostics Files 2026 Corporate Governance Statement with ASX
PremiumCompany Announcements
Lumos Diagnostics Files 2026 Corporate Governance Statement with ASX
11d ago
LDX
Lumos Diagnostics’ FY26 Milestones Expand FebriDx U.S. Market to Over US$1 Billion
PremiumCompany Announcements
Lumos Diagnostics’ FY26 Milestones Expand FebriDx U.S. Market to Over US$1 Billion
11d ago
LDX
Lumos Diagnostics Highlights Point-of-Care Innovation in 2026 Annual Report
PremiumCompany AnnouncementsLumos Diagnostics Highlights Point-of-Care Innovation in 2026 Annual Report
11d ago
LDX
Lumos Diagnostics Narrows Annual Loss as Revenue Grows but Going-Concern Risks Persist
Premium
Company Announcements
Lumos Diagnostics Narrows Annual Loss as Revenue Grows but Going-Concern Risks Persist
11d ago
LDX
Lumos Diagnostics to Showcase Infection-Focused POC Tech at Bioshares Summit
Premium
Company Announcements
Lumos Diagnostics to Showcase Infection-Focused POC Tech at Bioshares Summit
30d ago
LDX
Lumos Diagnostics Expands European Reach With FebriDx Deal in Romania
PremiumCompany Announcements
Lumos Diagnostics Expands European Reach With FebriDx Deal in Romania
1M ago
LDX
Lumos Diagnostics Updates Market on Director Doug Ward’s Increased Shareholding
PremiumCompany Announcements
Lumos Diagnostics Updates Market on Director Doug Ward’s Increased Shareholding
1M ago
LDX
Lumos Diagnostics Issues New Shares Through Employee Option Exercises
PremiumCompany Announcements
Lumos Diagnostics Issues New Shares Through Employee Option Exercises
1M ago
LDX
Lumos Diagnostics Launches Investor Roadshow and Quarterly Results Webinar
PremiumCompany Announcements
Lumos Diagnostics Launches Investor Roadshow and Quarterly Results Webinar
1M ago
LDX
Lumos Diagnostics FY26 Revenue Rises on FebriDx Surge Despite Services Slowdown
PremiumCompany AnnouncementsLumos Diagnostics FY26 Revenue Rises on FebriDx Surge Despite Services Slowdown
1M ago
LDX
Lumos Diagnostics Reports Lapse of 43,000 Performance Rights
Premium
Company Announcements
Lumos Diagnostics Reports Lapse of 43,000 Performance Rights
2M ago
LDX
Lumos Diagnostics Shuts Shareholder Loan as Capital Raise Leaves It Debt-Free
Premium
Company Announcements
Lumos Diagnostics Shuts Shareholder Loan as Capital Raise Leaves It Debt-Free
2M ago
LDX
Lumos Diagnostics Secures A$709,837 R&D Tax Rebate to Advance Point-of-Care Platforms
PremiumCompany Announcements
Lumos Diagnostics Secures A$709,837 R&D Tax Rebate to Advance Point-of-Care Platforms
2M ago
LDX
Lumos Diagnostics Director Sam Lanyon Increases Shareholding via On‑Market Purchase
PremiumCompany Announcements
Lumos Diagnostics Director Sam Lanyon Increases Shareholding via On‑Market Purchase
2M ago
LDX
Lumos Diagnostics Seeks ASX Quotation for 15.2 Million New Shares
PremiumCompany Announcements
Lumos Diagnostics Seeks ASX Quotation for 15.2 Million New Shares
3M ago
LDX
Lumos Diagnostics Director Catherine Robson Increases Indirect Shareholding
PremiumCompany Announcements
Lumos Diagnostics Director Catherine Robson Increases Indirect Shareholding
3M ago
LDX
Lumos Diagnostics Updates Director Doug Ward’s Expanded Equity Holding
PremiumCompany AnnouncementsLumos Diagnostics Updates Director Doug Ward’s Expanded Equity Holding
3M ago
LDX
Lumos ramps up U.S. rollout of FebriDx ahead of investor briefing
Premium
Company Announcements
Lumos ramps up U.S. rollout of FebriDx ahead of investor briefing
3M ago
LDX
Lumos Secures BARDA Milestone as FebriDx CLIA Waiver Unlocks US$1bn Market
Premium
Company Announcements
Lumos Secures BARDA Milestone as FebriDx CLIA Waiver Unlocks US$1bn Market
4M ago
LDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >